Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Pulmonary Artery Smooth Muscle Cell Senescence Is a Pathogenic Mechanism for Pulmonary Hypertension in Chronic Lung Disease
2011
Predicting Survival in Pulmonary Arterial Hypertension
2010 Standout
COVID-19 Infection
2020
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Bone Morphogenetic Protein (BMP) signaling in development and human diseases
2014 Standout
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study
2020
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Endothelin-1 Activation of the Endothelin B Receptor Modulates Pulmonary Endothelial CX3CL1 and Contributes to Pulmonary Angiogenesis in Experimental Hepatopulmonary Syndrome
2014
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
2014 Standout
Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: An analysis of cutoff values
2013
Ventilation/perfusion lung scan in pulmonary veno-occlusive disease
2011
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey
2012
Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease
2015
Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
2011
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
2010
Coronavirus disease (COVID-19) cases analysis using machine-learning applications
2021 Standout
Definitions and Diagnosis of Pulmonary Hypertension
2013 Standout
A global view of pulmonary hypertension
2016 Standout
High-flow nasal cannula oxygen for bronchiolitis in a pediatric ward: a pilot study
2013
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Obesity and inflammation: the linking mechanism and the complications
2016 Standout
Systemic sclerosis
2017 Standout
Clinical classification of pulmonary hypertension
2004 Standout
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study
2020 Standout
Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease
2017
Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era
2015 Standout
Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
2010
Changes in causes of death in systemic sclerosis, 1972–2002
2007 Standout
Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients With Advanced Cirrhosis
2010
International Liver Transplant Society Practice Guidelines
2016
A Novel Channelopathy in Pulmonary Arterial Hypertension
2013
A Central Role for CD68(+) Macrophages in Hepatopulmonary Syndrome
2010
Hepatopulmonary Syndrome — A Liver-Induced Lung Vascular Disorder
2008
EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension
2013
Bladder cancer
2016 Standout
Genetics and Genomics of Pulmonary Arterial Hypertension
2009
Hypoxia inducible factor-1-dependent up-regulation of BMP4 mediates hypoxia-induced increase of TRPC expression in PASMCs
2015 StandoutNobel
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
High-Flow Nasal Cannula Use in Children With Respiratory Distress in the Emergency Department
2013
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Pulmonary Angiogenesis in a Rat Model of Hepatopulmonary Syndrome
2008
Global burden of liver disease: 2023 update
2023 Standout
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study
2017
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials
2011
Pulmonary–Hepatic vascular Disorders (PHD)
2004
Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses
2013
Pilot study of pentoxifylline in hepatopulmonary syndrome
2008
Clinical risk factors for portopulmonary hypertension†
2008
Chemotherapy-Induced Pulmonary Hypertension
2014
The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report—2017; Focus Theme: Allograft ischemic time
2017 Standout
The Hyperdynamic Circulation of Chronic Liver Diseases: From the Patient to the Molecule
2006
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension
2013
Pulmonary veno-occlusive disease
2008
Genetics and Genomics of Pulmonary Arterial Hypertension
2013
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Bone morphogenetic protein signalling in heritableversusidiopathic pulmonary hypertension
2009
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Development of a machine learning algorithm to predict intubation among hospitalized patients with COVID-19
2020
A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
2014 Standout
BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension
2016
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Cellular senescence: from physiology to pathology
2014 Standout
Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertension
2014
Correction of Nonsense BMPR2 and SMAD9 Mutations by Ataluren in Pulmonary Arterial Hypertension
2013
Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension
2012
Pulmonary Arterial Hypertension in France
2006 Standout
Severe Pulmonary Arterial Hypertension Induced by SU5416 and Ovalbumin Immunization
2012
Pulmonary Hypertension Secondary to COPD
2012
BMPR2 Mutations Influence Phenotype More Obviously in Male Patients With Pulmonary Arterial Hypertension
2012
Prevalence and impact on survival of hepatopulmonary syndrome and cirrhotic cardiomyopathy in a cohort of cirrhotic patients
2015
Aging, Cellular Senescence, and Cancer
2012 Standout
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
Plasma C-Reactive Protein and Endothelin-1 Level in Patients with Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension
2010
Pulmonary Arterial Hypertension
2006
Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension
2015
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
2014
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services
2020 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
2015 StandoutNobel
Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients
2019
Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung
2015
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells
2013
Role of BMPR2 Alternative Splicing in Heritable Pulmonary Arterial Hypertension Penetrance
2012
Works of Benjamin Sztrymf being referenced
Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
2010
Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index
2016
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension
2009
Pulmonary Veno-Occlusive Disease
2008
Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: Younger and more severely affected patients
2014
Genes and Pulmonary Arterial Hypertension
2006
Pulmonary vascular abnormalities in cirrhosis
2007
Hypertension artérielle pulmonaire postembolique tumorale
2007
Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats
2004
Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation
2008
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases
2007
Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study
2011
Role for Interleukin-6 in COPD-Related Pulmonary Hypertension
2009
Genetic counselling in a national referral centre for pulmonary hypertension
2015
Cirrhotic rats with bacterial translocation have higher incidence and severity of hepatopulmonary syndrome
2005
Serotonin Transporter Polymorphisms in Familial and Idiopathic Pulmonary Arterial Hypertension
2005
An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy
2018
Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 ( ALK1 ) Mutation
2010
Humidified High Flow Nasal Oxygen During Respiratory Failure in the Emergency Department: Feasibility and Efficacy
2012
Use of High-Flow Nasal Cannula Oxygen Therapy in Subjects With ARDS: A 1-Year Observational Study
2014